4
Changes in Ownership
PROVECTUS BIOPHARMACEUTICALS, INC. Filed Acc 0001493152-21-015026
Options or other derivatives
- CFO acquired 0 shares (grant or award)
- CFO acquired 0 shares (option exercise)
- CFO acquired 20,289 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Raines Heather · CFO
Table II: Derivative
3 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2021-06-17 | Grant or award : show line 1 in the form 8% Secured Convertible Promissory Notes due 2021 | +0 | D | |
| 2021-06-20 | Exercise or conversion : show line 2 in the form 8% Secured Convertible Promissory Notes due 2021 | −0 | 0 | D |
| 2021-06-20 | Exercise or conversion : show line 3 in the form Series D-1 Convertible Preferred Stock | +20,289 | 20,289 | D |
Loading xslF345X03/ownership.xml…